🇺🇸 FDA
Patent

US 12157758

Readily isolated bispecific antibodies with native immunoglobulin format

granted A61KA61K2039/505

Quick answer

US patent 12157758 (Readily isolated bispecific antibodies with native immunoglobulin format) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/505